Director/PDMR Shareholding

RNS Number : 5626S
Aviva PLC
17 March 2021
 

17 March 2021

 

AVIVA PLC ("Aviva")

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs")

 

 

Aviva announces that:

 

Mark Versey, CEO Aviva Investors and PDMR, sold 62,000 ordinary shares, at a price of £3.93 on 16 March 2021. Full details of the transaction are set out below.

 

 

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

 

Media Enquiries:

Andrew Reid                                                                   + 44 (0)7800 694276

 

General Enquiries:

Roy Tooley, Company Secretarial    +44 (0)7800 699781

 

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

MARK VERSEY

2

Reason for the notification

a)

Position/status

CEO, AVIVA INVESTORS

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AVIVA PLC

b)

LEI

YF0Y5B0IB8SM0ZFG9G81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

SHARES

 

GB0002162385

b)

Nature of transaction

Sale of 62,000 ordinary shares in Aviva plc.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

£3.93

62,000

d)

Aggregated information

Aggregated volume

Price

 

 

£3.93 per share

Total Price £243,908

 

 

62,000

e)

Date of the transaction

2021-03-16

f)

Place of the transaction

LONDON STOCK EXCHANGE, XLON

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKDLBFFXLLBBE

Companies

Aviva (AV.)
UK 100

Latest directors dealings